Mirum Pharmaceuticals (MIRM) Change in Cash (2019 - 2026)

Mirum Pharmaceuticals' Change in Cash history runs 8 years deep, the most recent figure standing at $28.5 million for Q1 2026.

• In Q1 2026, Change in Cash rose 366.59% year-over-year to $28.5 million; the TTM figure through Mar 2026 stood at $114.4 million (up 226.27% YoY), while the FY2025 annual figure was $75.2 million, up 218.67% from the prior year.
• Change in Cash was $28.5 million for Q1 2026 at Mirum Pharmaceuticals, up from $15.7 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $147.8 million in Q2 2023 to a low of -$69.3 million in Q2 2024.
• Historically, Change in Cash has averaged $11.5 million across 5 years, with a median of $9.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Change in Cash plunged 273.23% in 2024, then jumped 3461.37% in 2025.
• A 5-year view of Change in Cash shows it stood at -$7.8 million in 2022, then tumbled by 115.74% to -$16.7 million in 2023, then surged by 97.22% to -$466000.0 in 2024, then surged by 3461.37% to $15.7 million in 2025, then soared by 81.79% to $28.5 million in 2026.
• The last three Change in Cash figures came in at $28.5 million (Q1 2026), $15.7 million (Q4 2025), and $53.9 million (Q3 2025), per Business Quant data.